These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11235816)

  • 1. Mode of antiviral activity of water soluble components isolated from Elfvingia applanata on vesicular stomatitis virus.
    Eo SK; Kim YS; Oh KW; Lee CK; Lee YN; Han SS
    Arch Pharm Res; 2001 Feb; 24(1):74-8. PubMed ID: 11235816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum.
    Eo SK; Kim YS; Lee CK; Han SS
    J Ethnopharmacol; 1999 Dec; 68(1-3):129-36. PubMed ID: 10624872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
    Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
    Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
    Romanutti C; Castilla V; Coto CE; Wachsman MB
    Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin.
    Barquero AA; Alché LE; Coto CE
    J Gen Virol; 2004 Feb; 85(Pt 2):483-493. PubMed ID: 14769906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
    Maarifi G; Hannoun Z; Geoffroy MC; El Asmi F; Zarrouk K; Nisole S; Blondel D; Chelbi-Alix MK
    J Virol; 2016 Jul; 90(14):6598-6610. PubMed ID: 27170750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication.
    Parker J; Ahrens PB; Ankel H
    Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antiviral activity of benzastatin C and its dechlorinated derivative from Streptomyces nitrosporeus.
    Lee JG; Yoo ID; Kim WG
    Biol Pharm Bull; 2007 Apr; 30(4):795-7. PubMed ID: 17409523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virucidal activity presence in Trichilia glabra leaves.
    Cella M; Riva DA; Coulombié FC; Mersich SE
    Rev Argent Microbiol; 2004; 36(3):136-8. PubMed ID: 15559196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of anti-vesicular stomatitis virus activity of deazaneplanocin and its 3-brominated analogs.
    Gibbons JS; Khadka S; Williams CG; Wang L; Schneller SW; Liu C; Tufariello JM; Basler CF
    Antiviral Res; 2021 Jul; 191():105088. PubMed ID: 34019950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
    Korutla L; Kumar R
    Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus.
    Romanutti C; Bruttomesso AC; Castilla V; Bisceglia JA; Galagovsky LR; Wachsman MB
    Vet J; 2009 Nov; 182(2):327-35. PubMed ID: 18682333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes.
    Fultz PN; Holland JJ
    Virus Res; 1985 Sep; 3(2):129-40. PubMed ID: 2414943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral and virucidal activities of Duabanga grandiflora leaf extract against Pseudorabies virus in vitro.
    Malik FZ; Allaudin ZN; Loh HS; Nee TK; Hani H; Abdullah R
    BMC Complement Altern Med; 2016 May; 16():139. PubMed ID: 27216794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus.
    Kim YS; Sagara J; Kawai A
    Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoinactivation of vesicular stomatitis virus with fullerene conjugated with methoxy polyethylene glycol amine.
    Hirayama J; Abe H; Kamo N; Shinbo T; Ohnishi-Yamada Y; Kurosawa S; Ikebuchi K; Sekiguchi S
    Biol Pharm Bull; 1999 Oct; 22(10):1106-9. PubMed ID: 10549864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of viral envelope sialic acid in membrane fusion mediated by the vesicular stomatitis virus envelope glycoprotein.
    Puri A; Grimaldi S; Blumenthal R
    Biochemistry; 1992 Oct; 31(41):10108-13. PubMed ID: 1327132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.